{"nct_id":"NCT01844505","title":"Phase 3 Study of Nivolumab or Nivolumab Plus Ipilimumab Versus Ipilimumab Alone in Previously Untreated Advanced Melanoma (CheckMate 067)","status":"COMPLETED","status_verified_date":"2025-05","start_date":"2013-06-11","start_date_type":"ACTUAL","primary_completion_date":"2016-08-01","primary_completion_date_type":"ACTUAL","completion_date":"2024-04-19","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["BMY"]}